RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,133 | -76.2% | 1,975 | -50.0% | 0.00% | – |
| Q2 2023 | $8,967 | +37.1% | 3,950 | +96.3% | 0.00% | – |
| Q1 2023 | $6,539 | +81637.5% | 2,012 | -0.4% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 2,020 | -0.3% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 2,027 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -50.0% | 2,027 | -50.4% | 0.00% | – |
| Q1 2022 | $16,000 | +166.7% | 4,083 | +98.6% | 0.00% | – |
| Q4 2021 | $6,000 | -33.3% | 2,056 | -0.3% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 2,062 | -4.4% | 0.00% | – |
| Q2 2021 | $8,000 | +33.3% | 2,157 | +16.8% | 0.00% | – |
| Q1 2021 | $6,000 | +50.0% | 1,846 | +53.6% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 1,202 | +9.8% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 1,095 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 1,095 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,095 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |